The Canadian Cancer Clinical Trials Network (3CTN)

The Canadian Cancer Clinical Trials Network (3CTN) is a pan-Canadian initiative to improve recruitment and the efficiency and quality of academic cancer clinical trials in Canada.

Our Impact at a Glance

What we achieved in 2018-2019:

223

Portfolio trials supported

4172

patients recruited to portfolio trials

72%

increase in patients above the pre-3CTN baseline

How We Deliver Impact

The 3CTN framework supports member cancer centres conducting research across the Network and engages patient voices at every step.

Our Partners

Our Canada-wide initiative is made possible by contributions from our funders and through collaborations with organizations who share our vision for the cancer clinical trial landscape.

Funding Partners

Collaborators